Efficacy of Low-Dose Oral Minoxidil in the Management of Anticancer Therapy-Induced Alopecia in Patients With Breast Cancer: A Retrospective Cohort Study

May 2023 in “ Journal of The American Academy of Dermatology ”

Jeewoo Kang, Ji Won Lee, Ohsang Kwon

We don't know much about this study yet.

We're maintaining the world's largest resposity of hair loss research. You can help out the community by sending a PDF of this study here . Not sure how to get a study's PDF? You can email the authors of the study.

View this study on jaad.org →

Discuss this study in the Community →

Cited in this study

3 / 3 results

research Clinicopathologic Characteristics and Response to Treatment of Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors

10 citations , November 2021 in “JAMA Dermatology”

Different types of persistent hair loss after chemotherapy respond differently to treatments.

research Minoxidil 1 mg Oral Versus Minoxidil 5% Topical Solution for the Treatment of Female-Pattern Hair Loss: A Randomized Clinical Trial

53 citations , January 2020 in “Journal of The American Academy of Dermatology”

Oral minoxidil and topical minoxidil 5% both effectively improve female-pattern hair loss with safe side effects.

research Assessment of Quality of Life and Treatment Outcomes of Patients With Persistent Postchemotherapy Alopecia

43 citations , June 2019 in “JAMA Dermatology”

Hair regrowth treatments had modest benefits for patients with long-term hair loss after chemotherapy.